TW201100135A - Hypodermic syringe with retractable needle - Google Patents
Hypodermic syringe with retractable needle Download PDFInfo
- Publication number
- TW201100135A TW201100135A TW98120786A TW98120786A TW201100135A TW 201100135 A TW201100135 A TW 201100135A TW 98120786 A TW98120786 A TW 98120786A TW 98120786 A TW98120786 A TW 98120786A TW 201100135 A TW201100135 A TW 201100135A
- Authority
- TW
- Taiwan
- Prior art keywords
- barrel
- plunger
- hypodermic syringe
- blocking
- occlusion device
- Prior art date
Links
- 230000000903 blocking effect Effects 0.000 claims abstract description 53
- 230000008878 coupling Effects 0.000 claims description 29
- 238000010168 coupling process Methods 0.000 claims description 29
- 238000005859 coupling reaction Methods 0.000 claims description 29
- 239000012530 fluid Substances 0.000 claims description 29
- 238000007920 subcutaneous administration Methods 0.000 claims description 20
- 238000002347 injection Methods 0.000 claims description 9
- 239000007924 injection Substances 0.000 claims description 9
- 238000007789 sealing Methods 0.000 claims description 9
- 230000000670 limiting effect Effects 0.000 claims description 6
- 230000035515 penetration Effects 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 4
- 230000000149 penetrating effect Effects 0.000 claims description 4
- 238000010254 subcutaneous injection Methods 0.000 claims description 3
- 239000007929 subcutaneous injection Substances 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims 1
- 239000000945 filler Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000001746 injection moulding Methods 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 230000003313 weakening effect Effects 0.000 description 2
- 241000238366 Cephalopoda Species 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 208000012266 Needlestick injury Diseases 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000003566 sealing material Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
201100135 六、發明說明: 【發明所屬之技術領域】 本發明係關於一種皮下注射器’其包含: 一筒身,其藉由其一内壁界定一貯液器,該筒身包含 一接近該筒身之一第一端之第一區段及一接近該筒身之一 第二端之第二區段, 一封堵裝置,其置放於該筒身之該第一區段中,以用 於封堵該筒身之該第一端’其中該封堵裝置具備一貫通 口’該貫通口向外地連通(debouch )於一經調適以用於一 與一針頭裝置之耦接之喷嘴中,及 一柱塞’其可滑動地置放於該筒身之該第二區段中, 以用於在穿透至該筒身中時將一流體推出於該筒身外,其 中該柱塞在該筒身之該第二端處至少部分地突出於該筒身 外,且其中該柱塞之一第一端插入於該筒身中且包含第一 耦接部件。 此等省知皮下注射器(特定言之,其嘴嘴)經標準化, =中各種不同針頭可置放於該喷嘴上。然而該等皮下注射 益之缺點為該針頭無法回縮至筒身中。關於可回縮針頭, 皮下注射器之構造需要徹底地調適。 【先前技術】 已開發用於使上面置放有針頭之喷嘴BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a hypodermic syringe comprising: a barrel defining an accumulator by an inner wall thereof, the barrel including a body adjacent to the barrel a first section of the first end and a second section adjacent to the second end of the barrel, a blocking device disposed in the first section of the barrel for sealing Blocking the first end of the barrel, wherein the occlusion device has a through opening, the through hole is outwardly connected (debouch) in a nozzle adapted for coupling with a needle device, and a column a plug slidably disposed in the second section of the barrel for pushing a fluid out of the barrel when penetrating into the barrel, wherein the plunger is in the barrel The second end protrudes at least partially outside the barrel, and wherein a first end of the plunger is inserted into the barrel and includes a first coupling component. These provinces know that subcutaneous syringes (specifically, their mouths) are standardized, and various needles can be placed on the nozzle. However, the disadvantage of such subcutaneous injection is that the needle cannot be retracted into the barrel. With regard to retractable needles, the construction of the hypodermic syringe needs to be thoroughly adapted. [Prior Art] A nozzle has been developed for placing a needle on the top
隨著時間推移, 回縮,- 其包含一 201100135 Ο ❹ 、—柱塞及-可回縮至該筒身,之針頭支座。該針頭 二由具備肩部之撓臂緊固至該筒身之第一開口端,該 :邛藉由置放一置放於該筒身中之第二直徑梯級處之額 外,狀體而與形成於筒身壁之凹穴中之肩部協作。此外, 該请身之第-開口端在該筒身中具備一用於使該針頭支座 搁置在^面的直徑梯級。因此,該針頭支座被限制在該筒 身中之第一直徑梯級與該額外環狀體之間。在一端面處, 該柱塞具備能夠收納該等撓臂之遠端之槽。該等槽具有若 >干表面’料表面對該等臂起作用以用於使該等臂脫離與 该等撓臂上之扣合卡鉤協作之凹穴及鎖扣,以使得該針頭 支座由及柱塞回縮。此皮下注射器之缺點為筒身及柱塞兩 者必須由大量分離部件構成。特定言之,將該環狀體置放 並附接於該筒身中之直徑梯級處為_ f力步驟。 自US 2003/0093038已知一參照構造。在該皮下注射器 中將》亥等臂设計為圓柱體壁部件,其置放於針頭支座之 周邊周圍且掷置靠著若干小凸輪,該等小凸輪置放於筒身 且延伸至該筒身中。參照凸輪亦置放成接近該筒 身之第一開口端以用於將該針頭支座限制於該筒身内。該 ^下注射器之缺點為亦歸因於該等凸輪,難以注射模製該 筒身。當自注射模移除該筒身時,該等凸輪常被損壞,此 引起無法獲得該針頭支座之正確限制。&夕卜,該針頭支座 及該柱塞歸因於其特定形狀而難以注射模製。最後,該皮 下注射器在該針頭支座中具有相對大的死空間。 本發明之目標在於提供皮下注射器之替代實施例,該 5 201100135 皮下注射器具有可回縮斜* 之標準 頭支座 拖針碩支座,可回縮至筒身 針頭可置放於該可回縮釙瓸* 难針碩支座上,且該可回縮針 可使用最小數目個部件以簡單方式製造。 本發明之目標由根據序部之皮下注射器達成 :裝置包含-密封地鄰接筒身之第-區段之内壁的圓周 其中該封堵裝置在背對喷嘴之側處具備一沿該封 置之-中心線且在該封堵裝置之全寬上延伸的凹穴, 穴朝該噴嘴之方向合併至貫通口中,纟中在該凹穴之: 上且朝該圓周壁延伸的兩個直徑上對置的可撓性第 部件置放於該凹穴中,_定部件藉由嗔合至該内壁中 之直徑上置放之鎖定凹槽中而鎖定該封堵裝置防止—在自 該第-端至該第二端之方向上的移動,其中該等鎖定部件 在其背對該喷嘴之末端處或接近該末端處包含用於 第一耦接部件之第二耦接部件, 其中該封堵裝置在背對該嘴嘴之側處、在該封堵裝置 之位於該凹穴外部之-圓周部分處具備兩個直徑上對置的 阻塞部件,該等阻塞部件大體平行於該封堵U之該中心 線延伸且徑向地向外延伸,阻塞部件藉由嚙合至泫内 壁中之直徑上置放之阻塞凹槽中而鎖定該封堵裝置防=一 在自a玄弟一端至該第一端之方向上的移動。 II由使用在該筒身之該内壁中之兩個直徑上置放之鎖 6 201100135 定凹槽來鎖定防士_ ^ , ο 在朝該筒身之第二端之方向上的蒋 動,且使用在該筒身^上的移 凹槽來阻塞防止:Γ 之兩個直徑上置放之阻塞 防止—在朝該筒身之第_ 其中該等鎖定四槽與 ’移動, 經由-簡單-射模製方法製;槽彼此不重疊’該筒身可 該第在端例中’等鎖定部件及該等鎖定凹槽在朝Over time, retraction, which includes a 201100135 Ο 、, - plunger and - can be retracted to the barrel, the needle holder. The needle 2 is fastened to the first open end of the barrel by a shoulder having a shoulder, and the 邛 is provided by placing an additional shape of the second diameter step placed in the barrel The shoulders formed in the pockets of the barrel wall cooperate. Further, the first open end of the body is provided with a diameter step in the barrel for resting the needle holder. Thus, the needle holder is constrained between the first diameter step in the barrel and the additional annular body. At one end, the plunger is provided with a slot that can receive the distal ends of the flexible arms. The grooves have recesses and latches that if the &# dry-surface material surfaces act on the arms for disengaging the arms from the snap hooks on the flex arms such that the needle branches The seat is retracted by the plunger. The disadvantage of this hypodermic syringe is that both the barrel and the plunger must be constructed of a large number of separate components. In particular, placing the annular body and attaching it to the diameter step in the barrel is a _f force step. A reference construction is known from US 2003/0093038. In the hypodermic syringe, the arm is designed as a cylindrical wall member placed around the periphery of the needle holder and thrown against a plurality of small cams placed on the barrel and extending to the In the barrel. A reference cam is also placed proximate the first open end of the barrel for restricting the needle mount within the barrel. The disadvantage of this lower syringe is that it is also attributed to the cams, which are difficult to injection mold. When the barrel is removed from the injection mold, the cams are often damaged, which causes the correct restriction of the needle holder to be obtained. & The needle holder and the plunger are difficult to injection mold due to their particular shape. Finally, the hypodermic syringe has a relatively large dead space in the needle holder. It is an object of the present invention to provide an alternative embodiment of a hypodermic syringe having a retractable oblique* standard head support needle holder that can be retracted to the barrel needle for retraction钋瓸* Difficult needle holders, and the retractable needles can be manufactured in a simple manner using a minimum number of parts. The object of the invention is achieved by a hypodermic syringe according to the sequence: the device comprises a seal-sealingly abutting the circumference of the inner wall of the first section of the barrel, wherein the occlusion device is provided with a seal along the side facing away from the nozzle - a central line and a recess extending over the full width of the occluding device, the hole being merged into the through opening in the direction of the nozzle, the two diametrically opposed upper and lower sides of the recess The flexible first member is placed in the recess, and the locking member is locked by being twisted into the locking groove placed in the diameter of the inner wall to prevent - from the first end to Movement in the direction of the second end, wherein the locking members include a second coupling member for the first coupling member at or near the end thereof facing away from the nozzle, wherein the blocking device is Provided at the side of the mouthpiece at the circumferential portion of the occlusion device at the outer portion of the pocket, two diametrically opposed blocking members, the blocking members being substantially parallel to the center of the occlusion U The wire extends and extends radially outwardly, and the blocking member is engaged by Placed on the inner diameter wall of the weep blocking recess of the locking means preventing plugging from a black = a brother in one end to the movement direction of the first end of the. II is locked by a lock 6 201100135 placed on the two diameters of the inner wall of the barrel to lock the guard _ ^ , ο in the direction toward the second end of the barrel, and Use the groove on the barrel to block the blockage: 阻塞 the two diameters placed on the blockage prevention - in the direction towards the barrel _ where the lock four slots and 'moving, via-simple-shot Molding method; the grooves do not overlap each other 'the barrel can be in the end example' and the locking members and the locking grooves are facing
GG
形成一形扣合,且該等阻塞部件及該等 之St第—端之方向上形成-形扣合。此形扣合 人 ,為阻塞或鎖定部件至各別凹槽中之搭扣唾 :緣或2施例為:鎖定部件具有—面朝該第二端之鄰接 二:° 2 —鎖定凹槽具有-面朝該第-端之鄰接邊 、:“。另-實施例為一阻塞部件具有一面朝該第一端 之鄰接邊緣或肩部,且-阻塞凹槽具有—面朝該第二端之 鄰接邊緣或肩部。 ▲在一項實施例中,該等鎖定部件與該等鎖定凹槽在朝 »亥第端之方向上形成—力扣合。此力扣合之—項實施例 為一較部件具有-面朝該第—端且與注射器之中心線成 銳角之斜面’且鎖定凹槽具有—制n該設計使得有 可能將使該筒身之内部或接近該等鎖定凹槽處成形的注射 模之模核部分經由該筒身之第一端自該筒身取出,其甲該 筒身暫時變形而大體上無損壞。 在一項實施例中,該筒身之在其背對第一端之一側處 之第一區段係由一圓周邊緣接臨,其_該第一區段具有一 小於該筒身之位於超出該邊緣處之一部分的内徑,其中該 7 201100135 阻塞凹槽形成於該第一區段中且連通於該邊緣中。在一項 實施例中,該阻塞凹槽之底面與該筒身之位於超出該邊緣 處之部分置放於距離該筒身之中心線之大體相同距離處。 此設計使得有可能將使該筒身之内部或接近該等阻塞凹槽 處成形的注射模製之模核部分經由該筒身之第二端自該筒 身滑出無損壞。 在項貝施例中,該等鎖定凹槽與該等阻塞凹槽大體 置放於位於在該筒身之内側處之同—圓周處。在—項實施 例中,-經過該等阻塞凹槽之中心線之第—平面置放成大 體垂直於經過該等鎖定凹 實施例中,該第一平面與 皮下注射器之中心線重合 槽之中心線之第二平面。在一項 忒第二平面之間的一相交線與該 為了使包括該針頭裝置之封堵裝置回縮,該柱塞之末 端具備第-耦接部件,且該封堵裝置具有與第—純構件 協作之第二耦接部件。以該方式,該柱塞可耦接至該封堵 裝置以用於使包含該柱塞或活塞'該封堵裝置及該針頭裝 置之總成回縮至該筒身巾。在—項實施例中,該等第一輕 接部件及該等第三純部件經調適以用於解鎖該等鎖定部 件與該等鎖定凹槽之鎖定。#由解鎖該等鎖定部件,產生 用於使該封堵裝置移動至該筒身中之自由。藉由在實㈣ 該柱塞或活塞之㈣期間解鎖該封堵裝置,在該柱塞處^ 拉動運動之狀況下,該封堵裝置被—起帶動。 在該皮下注射器之一項實施例中,該筒身之該第—區 段之該内壁為大體圓柱形的或在一自該筒身之該第—端朝 201100135 向上具有一增加直徑過程。因此描述之筒身 實施例的-又部=計為具有用於該封堵裝置之釋放情形之 在該封堵裝置之-項實施例中 以用於_# 贺嘴之尺寸經调適 、4用於或欲用於標準皮下注射器、尤為無回 鈿裝置之皮下注射器之針頭或針頭裝 標準針頭或針頭裝置可在使用之後 “ Ο Ο 而儲存於該筒身卜藉由提供具有^ 封料置回縮 喷嘴的封堵裝置,組織可能夠 ::習知針頭之 習知針頭,且將皮下注射器二1!:購貝限於該等標準 購貝大體限於根據本發明之 =:器。歸因於該標準喷嘴,根據本發明之皮下注射 盗亦可麵接至其他裝置’諸如,滴液器。 第項實施例中,該封堵裝置包含-接近該筒身之該 ::端之第-端,其中該第一端之直徑超過該標準針頭裝 -直控。因而,該針頭裝置之具有橫向於 之縱向量測的最大直徑的部分亦適配該筒身之第一端。 ^一項實施例中’該封堵裝置在該第一端處之該直徑 ^過6職,較佳地超過8咖。通常使用具有此等尺寸之 =且因而’提供具有可回縮針頭裝置之皮下注射器, 主射器上’具有根據組織中之標準之尺寸的所有 针頭均可加以使用。 在一項實施例中,包含-大體圓柱形内壁之該筒身之 ^第一區段的一内徑超過或等於該封堵裝置之一外秤。以 該方式,該封堵裝置之具有橫向於該封堵裝置之縱向工量測 9 201100135 的最大直徑的部分亦適配該筒身之第二端。 产在一項實施例中,該柱塞在最深穿透之情形下插入於 該筒身中之該末端之形狀大體吻合該封堵襞置之存在於該 筒身中之該末端之形狀。以此方式,由流體佔據之容積由 柱塞之體積填充,因而,在注射之後流體留在筒身中之剩 餘體積保持限於最小量。 在一項實施例中,該柱塞具備一至少部分地填充該貫 通口之填充體。以此方式,在喷嘴中之流體亦至少部分地 被推出於該噴嘴外。 在-項實施例中,該皮下注射器包含_經調適以用於 阻塞该柱塞朝該筒身之該第之 m , -a· ^ ^ . J 移動的制動機 =夷中該制動機構在一第一位置中接臨待穿透該筒身之 該柱塞之該第—端不使其自身麵接至該封 筒身之動機構在—第二位置令允許待穿透該 二基相接至該封堵裝置。為了吸取流體,有必要 靶冰地將該柱塞插入至該筒身 時已耦桩01 ^ 然而,若該柱塞此 拉動。為;防^吏該柱塞回縮時,該封堵裝置亦將被—起 之移動定/ 況,該制動機構在第-位置中對柱塞 現麵接/,以使得該柱塞之轉接構件與該封堵裝置不實 之輕2將該針頭收容在該筒身中,確實有必要使該柱夷 件與該封堵裝置形成耗接。 : 使忒制動機構達到其第二 曰的需要 更深地進入至ηI+ ,此情況確保該柱塞能夠 至4身中,以使得耦接得以實現。 10 201100135 ”-項實施例中,該制動機構在該第二位置中阻塞 該枉塞及該封堵裝置之總成防止該總成朝該筒身之該 弟-:之方向刺穿。當該封堵農置因一穩定按壓力稍微推 出於冋身外時,將難以將該封堵裝置再次推回至内部,在 面此睛況亦必然伴有將針頭疏忽地刺入某人之皮膚 的風險、。當該制動機構在其第二位置中時,會防止該封堵 裝置可被推出於該筒身外。 —在一項實施例中,該制動機構配置成接近該柱塞之該 〇帛二端。以此方式,其已使得有可能實現使容易地接取之 操作成為可能的簡單構造。 在員實施例中,該筒身包含一用於導引該柱塞之導 引襄置。在—項實施例中,該導引裝置(至少其第一端) 嚙《至該柱塞上以用於固定該柱塞在皮下注射器之中心線 周圍的定向。 在一項實施例中,該導引裝置包含第一連接構件,且 β筒身包含與該等第—連接構件協作之第二連接構件,其 ϋ中該等第一連接構件及該等第二連接構件經調適以用於該 導引裝置與該筒身之一連接。當在工廠中組裝該皮下注射 器時,首先將該封堵裝置及該柱塞引入至該筒身中。可將 該導引裝置置放於該導引裝置使該筒身之第二端處之開口 元全自由的第一情形中,且可將該導引裝置置放於該導引 裝置部分地插入至該筒身之第二端處之開口中且嚙合至柱 塞上以用於其旋轉固定之導引的第二情形中。為了使該等 第一耦接構件與該等第二耦接構件完全耦接,該柱塞之關 11 201100135 於㈣堵裝置之㈣定向可相要的。使 解鎖亦需如此。該柱塞-充足地置放且定二於疋部件 該導引裝置之連接構件在於該筒身中, 之連接構件。 、第-清形中即可連接至該筒身 在一項實施例中,該柱塞包含一 M^^ 3在該桂塞之縱向上延 伸之肋,且該導引裝置包含一 、 何插入位置中至少部μ…在該柱塞可處之任 包圍該肋之突出部分的末端。以 此方式’當推入該柱塞且 該導引裝置導引。^㈣回縮時’㈣持續地由 在一項實施例中,該柱塞包含用於抵靠(check)該筒 身上之㈣引裝置之移動限制構件,料構件對該柱塞朝 該筒身之該第二端之方向之一移動定界。以此方式,界定 該柱塞之關於該筒身之位置,其中可斷開該筒身。 在貞實她例中,该检塞構造有一用於斷開並分裂該 柱塞之^物’其中該_物特定置放成接近該柱塞之存 在於“向身中之β玄末知。當該削弱物剛好在該筒身外部 時,該柱塞可自該經回縮之總成分裂。該皮下注射器之長 度因此粗略地一等分。了廢料被更有效地處理之事實之 外’分裂更是移除針頭意外地再次被推出於該筒身外的風 險0 在一項貫施例中,包含—大體圓柱形内壁之該筒身之 該第二區段具有一超過或等於該筒身之該第一區段之一橫 載面的橫截面。以該方式,在該第二區段中可獲得用於注 射或吸取更大量流體的容積。此外,有可能無關於該皮下 12 201100135 注射器之厚度而在該皮下注射器中使用相同 :而投予(例如)3cc流體之皮下注射器之筒身: 第一口又在其全長上可具有相同内徑。在用於投予較大☆ 積之皮下注射器之筒身之狀況下,該筒身之具有内徑之2 一區段可設計成具有一所要周長(girth )。 ΟForming a snap fit, and the blocking members and the St-ends of the St-ends form a snap-fit. The snap fits into the buckle or the locking member into the respective groove in the respective groove: the edge or the second embodiment is: the locking member has - the abutment facing the second end: ° 2 - the locking groove has - facing the abutting edge of the first end, ". another embodiment is a blocking member having an abutting edge or shoulder facing the first end, and - the blocking groove has - facing the second end Adjacent edge or shoulder. ▲ In one embodiment, the locking members and the locking recesses are formed in a direction toward the first end of the -heel. The force is engaged. A relatively component has a bevel that faces the first end and is at an acute angle to the centerline of the syringe and the locking recess has a design that makes it possible to bring the interior of the barrel into or near the locking recesses The core portion of the formed injection mold is removed from the barrel through the first end of the barrel, and the barrel is temporarily deformed to be substantially free of damage. In one embodiment, the barrel is facing away from it. The first section at one side of the first end is adjacent to a circumferential edge, and the first section has a An inner diameter of the barrel at a portion beyond the edge, wherein the 7 201100135 blocking groove is formed in the first section and communicates with the edge. In one embodiment, the blocking groove The bottom surface and the portion of the barrel beyond the edge are placed at substantially the same distance from the centerline of the barrel. This design makes it possible to shape the interior of the barrel or near the blocking groove. The mold portion of the injection molding slides out from the barrel through the second end of the barrel without damage. In the example of the item, the locking grooves and the blocking grooves are generally placed at the The same at the inner side of the barrel - the circumference. In the embodiment, - the first plane passing through the center line of the blocking grooves is placed substantially perpendicular to the embodiment through the locking recesses, the first a second plane of the centerline of the plane coincident with the centerline of the hypodermic syringe. An intersection line between a second plane and the end of the plunger for retracting the occlusion device including the needle device Having a first coupling component and the The blocking device has a second coupling member that cooperates with the first pure member. In this manner, the plunger can be coupled to the occlusion device for including the plunger or piston 'the occlusion device and the needle device The assembly is retracted to the body towel. In the embodiment, the first light member and the third pure member are adapted to unlock the locking member and the locking groove By unlocking the locking members, a freedom is created for moving the occlusion device into the barrel. The occlusion device is unlocked during the (d) (d) of the plunger or piston at the plunger ^ In the case of a pulling motion, the occlusion device is actuated. In an embodiment of the hypodermic syringe, the inner wall of the first section of the barrel is substantially cylindrical or in a cylinder The first end of the body has an increasing diameter process upwardly toward 201100135. Thus, the embodiment of the barrel embodiment is described as having the release condition for the occlusion device in the occlusion device. Used to adjust the size of _# Hezui, 4 used or intended to be used A hypodermic syringe, especially a hypodermic needle of a hypodermic device, or a standard needle or needle device that can be stored in the barrel after use, by providing a occlusion device having a retraction nozzle with a sealing material The tissue may be able to:: conventional needles of conventional needles, and to limit the subcutaneous syringes to the standard: the purchase of the shells is generally limited to the apparatus according to the invention. Due to the standard nozzle, the subcutaneous injecting pirate according to the present invention can also be interfaced to other devices such as a drip dispenser. In a first embodiment, the occlusion device includes - near the first end of the :: end of the barrel, wherein the diameter of the first end exceeds the standard needle mount - direct control. Thus, the portion of the needle device having a maximum diameter transversely measured longitudinally also fits the first end of the barrel. In one embodiment, the diameter of the occlusion device at the first end is more than six, preferably more than eight. A hypodermic syringe having such dimensions and thus providing a retractable needle device having all of the needles having a size according to the standard in the tissue can be used. In one embodiment, an inner diameter of the first section of the barrel comprising the generally cylindrical inner wall exceeds or equals one of the outer scales of the occlusion device. In this manner, the portion of the occlusion device having a maximum diameter transverse to the longitudinal dimension of the occlusion device 9 201100135 is also adapted to the second end of the barrel. In one embodiment, the shape of the end of the plunger inserted into the barrel in the deepest penetration substantially conforms to the shape of the end of the occlusion device present in the barrel. In this way, the volume occupied by the fluid is filled by the volume of the plunger, and thus the remaining volume of fluid remaining in the barrel after injection remains limited to a minimum. In one embodiment, the plunger has a filler body that at least partially fills the through opening. In this way, the fluid in the nozzle is also at least partially pushed out of the nozzle. In the embodiment, the hypodermic syringe includes a brake adapted to block the plunger toward the first m, -a·^^. J movement of the barrel. In the first position, the first end of the plunger adjacent to the barrel to be penetrated does not have its own surface attached to the mechanism of the sealing body. The second position allows the two bases to be penetrated to be connected to The occlusion device. In order to draw the fluid, it is necessary to couple the plunger to the barrel when the target is inserted into the barrel. However, if the plunger is pulled. In order to prevent the plunger from retracting, the occlusion device will also be moved in the same position, and the brake mechanism will face the plunger in the first position to make the plunger rotate. The connecting member and the blocking device are not light 2. The needle is housed in the barrel, and it is indeed necessary to make the staging member and the blocking device to be consumable. : The need to bring the brake mechanism to its second position deeper into ηI+, which ensures that the plunger can be placed into the body 4 so that coupling is achieved. 10 201100135 ― In the embodiment, the brake mechanism blocks the dam and the assembly of the occlusion device in the second position to prevent the assembly from piercing in the direction of the body of the barrel. When the blocked agricultural device is slightly pushed out of the body due to a stable pressing pressure, it will be difficult to push the blocking device back to the inside again. In this case, the needle must be inadvertently pierced into someone's skin. Risk, when the brake mechanism is in its second position, prevents the occlusion device from being pushed out of the barrel. - In one embodiment, the brake mechanism is configured to access the ram of the plunger In this way, it has made it possible to implement a simple configuration that makes it easy to access the operation. In an embodiment, the barrel comprises a guiding device for guiding the plunger In the embodiment, the guiding device (at least its first end) is threaded onto the plunger for securing the orientation of the plunger about the centerline of the hypodermic syringe. In one embodiment, The guiding device includes a first connecting member, and the beta barrel includes the same a second connecting member in which the first connecting member cooperates, wherein the first connecting member and the second connecting member are adapted for the guiding device to be coupled to one of the barrels. When assembled in the factory In the case of a hypodermic syringe, the occlusion device and the plunger are first introduced into the barrel. The guiding device can be placed on the guiding device to make the opening element at the second end of the barrel free. In one case, the guiding device can be placed in the opening of the guiding device partially inserted into the opening at the second end of the barrel and engaged to the plunger for guiding the rotation thereof In the second case, in order to fully couple the first coupling members with the second coupling members, the alignment of the plungers 11 201100135 to the (four) blocking device may be desirable. The plunger is sufficiently placed and fixed to the jaw member. The connecting member of the guiding device is in the barrel, the connecting member. The first clearing can be connected to the barrel in one embodiment. The plunger includes a rib extending in the longitudinal direction of the cassia plug, and the guide The device includes a distal end of at least a portion of the insertion position at which the plunger can be placed to surround the protruding portion of the rib. In this manner 'when the plunger is pushed in and the guiding device is guided. ^(d) [004] Continually, in one embodiment, the plunger includes a movement limiting member for inspecting (4) the guiding device on the barrel, the material member facing the plunger toward the barrel One of the directions of the two ends is moved and delimited. In this way, the position of the plunger with respect to the barrel is defined, wherein the barrel can be broken. In the case of tamping, the plug configuration has a function for disconnecting And splitting the plunger of the object, wherein the object is placed in proximity to the presence of the plunger in the "into the body." When the weakener is just outside the barrel, the plunger can split from the retracted assembly. The length of the hypodermic syringe is therefore roughly equally divided. In addition to the fact that the waste is being processed more efficiently, 'splitting is the risk of removing the needle from being accidentally pushed out of the barrel again. In one embodiment, the barrel containing the generally cylindrical inner wall is included. The second section has a cross section that is greater than or equal to one of the cross sections of the first section of the barrel. In this way, a volume for injecting or aspirating a larger amount of fluid can be obtained in the second section. In addition, it is possible to use the same in the hypodermic syringe regardless of the thickness of the subcutaneous 12 201100135 syringe: the barrel of the hypodermic syringe administered, for example, 3 cc fluid: the first port may have the same inner diameter over its entire length . In the case of a barrel for administering a larger hypodermic syringe, the barrel having an inner diameter of 2 can be designed to have a desired girth. Ο
在一項實施例中,該柱塞具備一至少部分地填充該封 堵裝置中之該凹穴及該貫通口之填充體。以此方式,由流 體佔據之容積由柱塞之體積填充,因π,在注射之後流體 留在筒身中之義體積保持限於最小量。由於該柱塞具備 -至少部分地填充該貫通口之填充體,在該喷嘴中之流體 亦至少部分地被推出於該喷嘴外。 在-項實施例中,該封堵裝置在一位於接近該筒身之 該第一端處之末端處具備一在該封堵裝置周圍伸展且徑向 地向外延伸之肋,其中該肋與該封堵震置整體地形成。該 肋確保該封堵裝置與該筒身之内壁之間的足夠密封。 亦可在可能時個別地使用在此描述及本申請案之申請 專利範圍中描述及/或在本巾請案之圖式中展示之態樣及方 法。諸如在該柱塞之末端處之填充體(使用該填充體,流 體在注射之後留在該筒身中之剩餘體積限於最小量)之該 等個別態樣及其他態樣可為與此相關之專利申請分案之標 的此情況尤其適用於本身在附屬項中描述之方法及態樣。 【圖式簡單說明】 圖1展示在分解情形下之皮下注射器之第一例示性實 13 201100135 施例的透视圖; 圓! A展示筒身之第一側視 情形中; 中封堵裝置位於鎖定 圖展示筒身之第二側視 情形中; 固〃中封堵裳置位於鎖定 圖1C展示阻塞部件之細節, 而阻塞於筒身中; 由該阻塞部件 -二;裝T.1之皮下注射器之橫截面,其中柱塞位於 位置;裝置之耗接尚未實現且流體之吸取可加以執行的 圖3展不圖1之出ΠΓ、、士 44· 口口 自筒身解鎖;皮下庄射③之橫截面,其中封堵裝置 圖4展不圖1之皮下注射器之構 搞接至柱塞; 15之面’其中封堵裝置 圖5展不圖1夕士 及柱塞之總成㈣微回縮橫戴面,其中封堵裝置 其二機展:二之:1::中’之位於該筒身中’ 圖7展不筒身之側視圖,所插 其中制動機構處於第—位置中所插人枝塞位於則身中, 圖 8展+祥& 敬不同身之側視圖,突中 其中制動機構處於第二位置中Γ出之柱塞位於_身中, 圖 9 展& a 其中制動機;1身='=圖+所插入柱塞位於該筒身中, 14 201100135 圖10A展示導引裝置未使用連接構件連接至筒身之透 視圖, 圖10B展示導引裝置未使用連接構件連接至筒身之正 視圖; 圖11展示導引裝置確實使用連接構件連接至筒身之透 視圖; 圖12展示一所插入柱塞、筒身之一部分及導引裝置之 透視圖’其中導引構件使用連接構件連接至筒身;In one embodiment, the plunger is provided with a filler that at least partially fills the recess and the through opening in the occluding device. In this way, the volume occupied by the fluid is filled by the volume of the plunger, and due to π, the volume of fluid remaining in the barrel after injection remains limited to a minimum. Since the plunger has a filling body that at least partially fills the through opening, the fluid in the nozzle is also at least partially pushed out of the nozzle. In the embodiment, the occlusion device has a rib extending around the occlusion device and extending radially outwardly at a distal end adjacent the first end of the barrel, wherein the rib is The plugging shock is integrally formed. The ribs ensure a sufficient seal between the occlusion device and the inner wall of the barrel. The aspects and methods described herein and/or illustrated in the drawings of the present application may also be used individually wherever possible. Such individual and other aspects, such as the filler at the end of the plunger (using the filler, the remaining volume of fluid remaining in the barrel after injection is limited to a minimum amount) may be relevant thereto. This is particularly the case for the patent application split case, which applies in particular to the methods and aspects described in the subsidiary. BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 shows a perspective view of a first exemplary embodiment of a hypodermic syringe in a disassembled situation; 201100135; A shows the first side view of the barrel; the middle occlusion device is located in the second side view of the lock figure display cylinder; the occlusion in the solid raft is located in the lock Figure 1C shows the details of the blocking part, and is blocked In the barrel; from the blocking member - two; the cross section of the hypodermic syringe containing T.1, wherein the plunger is in position; the consumption of the device has not been achieved and the suction of the fluid can be performed. ΠΓ,,士44· The mouth is unlocked from the barrel; the cross section of the subcutaneous razor 3, in which the occlusion device is shown in Figure 4, the subcutaneous syringe of Fig. 1 is connected to the plunger; Figure 5 shows the assembly of the Xi Shi and the plunger (4) micro-retracted cross-face, in which the blocking device has two machine exhibitions: two: 1:: 'in the cylinder' a side view of the barrel in which the brake mechanism is placed in the first position, and the inserted plug is located in the body. Figure 8 shows the side view of the different body, in which the brake mechanism is in the second position. The plunger that is pulled out is located in the body, Figure 9 shows & a where the brake; 1 body = '= figure + inserted plunger is located In the barrel, 14 201100135 FIG. 10A shows a perspective view of the guiding device connected to the barrel without using a connecting member, and FIG. 10B shows a front view of the guiding device connected to the barrel without using a connecting member; FIG. 11 shows that the guiding device does use Figure 12 shows a perspective view of the insertion plunger, a portion of the barrel and the guiding device 'where the guiding member is connected to the barrel using the connecting member;
圖13展示一所回縮柱塞、筒身之一部分及導引裝置之 透視圖,其中柱塞上之鄰接凸輪鄰接導引構件; 圖14展示一折斷之柱塞、筒身之一部分及導引裝置之 透視圖, 圖1 5展示一加厚皮下注射器之側視圖; 圖1 6展示一加厚皮下注射器之側視圖; 之第二例示性實 圖17展示在分解情形下之皮下注射器 施例的透視圖;Figure 13 shows a perspective view of a retracting plunger, a portion of the barrel and a guiding device, wherein the abutment cam on the plunger abuts the guiding member; Figure 14 shows a broken plunger, a portion of the barrel and a guide A perspective view of the device, Figure 15 shows a side view of a thickened hypodermic syringe; Figure 16 shows a side view of a thickened hypodermic syringe; and a second exemplary embodiment 17 shows a hypodermic syringe embodiment in the exploded condition perspective;
圖18A展示筒身之第一側視圖 定情形中; 其中封堵裝置位於鎖 其中封堵裝置位於鎖 圖18B展示筒身之第二側視圖 定情形中; 圖19A展示圖 於一與封堵裝置之 的位置中; 17之皮下注射器之橫截面,其中柱塞位 輕接尚未實現且流體之吸取可加以執行 圖19B展示圖 17之皮下注射器之橫載面 其中封堵裝 15 201100135 置自筒身解鎖; 圖19C展示圖 置輕接至柱塞; ,其中封堵裝 圖丨91)展示圖17之皮下注射器之橫戴面 置及柱塞之總成已稍微回縮至筒身中; 圓20A展示-所插入柱塞、筒身之—部分及導引裝置 之透視圖,其中導引構件使用連接構件連接至筒身; 圖20B展示一所回縮柱塞、筒身之—部分及導引裝置 之透視圖,其中柱塞上之鄰接凸輪鄰接導引構件; ,圖20C展示一折斷之柱塞、筒身之_部分及導引裝置 圖21展示皮下注射器之第三例示性實施例的透視圖, 該皮下注射器包含可拆卸地置放於筒身之遠端處之 頭總成,#中一柱塞可移動地置放於該筒身中; 圖22展示圖21之筒身及柱塞的橫截面圖·, 圖23展示根據本發明之皮下針頭總成之透視圖; 圖24展示圖23之皮下針頭總成之橫截面圖,其中一 錨座可拆卸地置放於輪轂中且—皮下針頭連接至該錨座; 圖25展示圖24之錯座之橫截面圖,其具有—大 柱形遠端部分及在向外定向之搭扣元件中終止之若干可撓 性支腳且包含制動構件; & -圖26展不與圖24相當之視圖,其中放大環繞部分展 不由輪轂及錨座界定之密封唇緣; 圖27A展示圖21之 射盗之部分橫截面圖,其中該才主 16 201100135 塞之遠端在筒身之一部分内部;Figure 18A shows a first side view of the barrel; wherein the occlusion device is located in the lock, wherein the occlusion device is located in the second side view of the barrel shown in Figure 18B; Figure 19A shows the occlusion device In the position of the subcutaneous syringe of 17; wherein the plunger position is not yet achieved and the fluid suction can be performed. Figure 19B shows the cross-loading surface of the hypodermic syringe of Figure 17 with the closure 15 201100135 placed from the barrel Figure 19C shows the light connection to the plunger; wherein the closure assembly 91) shows the cross-face of the hypodermic syringe of Figure 17 and the assembly of the plunger has been slightly retracted into the barrel; A perspective view of the inserted plunger, the barrel portion, and the guiding device, wherein the guiding member is coupled to the barrel using a connecting member; FIG. 20B shows a retracting plunger, a portion of the barrel, and a guide A perspective view of the device in which the abutting cam on the plunger abuts the guiding member; Figure 20C shows a broken plunger, a portion of the barrel and a guiding device. Figure 21 shows a perspective view of a third exemplary embodiment of a hypodermic syringe. Figure, the skin bet The ejector includes a head assembly detachably disposed at a distal end of the barrel, wherein a plunger is movably placed in the barrel; FIG. 22 shows a cross section of the barrel and the plunger of FIG. Figure 23 shows a perspective view of a hypodermic needle assembly in accordance with the present invention; Figure 24 shows a cross-sectional view of the hypodermic needle assembly of Figure 23 with an anchor seat removably placed in the hub and - a hypodermic needle connection Figure 25 shows a cross-sectional view of the wrong seat of Figure 24 having a large cylindrical distal end portion and a plurality of flexible legs terminating in the outwardly oriented snap elements and including a brake member; & Figure 26 shows a view that is not comparable to Figure 24, with the enlarged surrounding portion showing the sealing lip not defined by the hub and the anchor; Figure 27A shows a partial cross-sectional view of the shooting pirate of Figure 21, wherein the master 16 201100135 The distal end of the plug is inside a portion of the barrel;
圖27B展示與圖27A 遠端位置; ^視® ’其中該柱塞處於更 ,27C展示與圖2Μ及圖27β相當之視圓且中該柱 塞之遠端在筒身内部處於完全遠端位置中,其中錨座之可 撓性支腳在柱塞内部; 、 示與圖27Α至圖27c相當之視圖,其具有該 柱塞之向外疋向之搭扣元件; ΟFigure 27B shows the distal position with Figure 27A; ^ see ® 'where the plunger is at a greater angle, 27C shows a circle equivalent to Figure 2A and Figure 27β and the distal end of the plunger is at a fully distal position inside the barrel Wherein the flexible leg of the anchor seat is inside the plunger; and is shown in a view corresponding to FIG. 27A to FIG. 27c, which has the outwardly facing snap element of the plunger;
G 柱夷之」展不與圖Μ至圖27D相當之視圖,其具有該 土疋王回縮’錯座及針頭被拉動至筒身内部; 圖28展示圖22之、、*私έ 射态同身之透視圖,其中切去筒 身之一。P为以便揭示柱塞之遠端; 圖29展示柱塞之透視圖; 柱塞I:二展示柱塞之遠端之一放大部分透視圖,其包括 往塞之搭扣邊緣; 圖_展示柱塞之遠端之另一放大部分透視圖;及 射汽身展丁圖21之注射器之橫截面圖’其中柱塞在注 、旖身内處於不同處理步驟處。 【實施方式】 施例闡 本發明將基於隨附圖s 明 思附圖式中展示之若干例示性實 在下文中將在參看圖式的同時描述本發明之若干例示 性實施例。 17 201100135 圖1為皮下注射器之分解透視圖,且展示柱塞丨(亦稱 為活塞)、筒身2 (亦稱為貯液器或殼體)、封堵裝置3 (亦 稱為針頭支座或銷座)及針頭裝置4。 筒身2具有大體圓柱形内壁,且包含在第二端52處之 用於固持該皮下注射器之凸緣21及背對該筒身之第 第一端5 1。 該封堵裝置3經調適以用於封堵該筒身2之第—沪 5卜其中該封堵裝置3具備-貫通口31,該貫通^向= 地連通至經調適以用於耦接至一針頭裝置4之噴嘴W中 ^封堵裝m背對喷嘴32之側處包含第二__ A可將柱塞I可移動地置放於筒身2中^^ 該筒身2中時將流體推出於該筒身外, A . ^ 、甲S亥柱塞1在筒 身之第二端52處至少部分地突出於筒身 。 第-…入於筒身2中。該柱塞之V對卜第:塞1之 二端62包含一按壓部分u。該柱塞 糕61之第 一耦接構件k2協作之第一耦接構件Η,其 ,、弟 kl及第二麵接構#k2經調適以用於*弟—純構件 3之耦接,以便在該筒身2中朝該筒身2之 山 裒置 向移動該柱塞1及該封堵裝置3之總成。一鳊62之方 該封堵裝置3在此狀況下為在該筒身2 以使得該封堵裝置3 (視情況包括—針頭 J移動的, 該筒身”,其中該封堵裝置3 可回縮至 之第-端51處密封地鄰接該筒身2之4至少在該筒身2 18 201100135 该封堵裝置3具備_噴嘴32,其中該” 調適以用於-與-標準針頭或針頭裝置4之輕接,外準 針頭或針頭裝置4通常適用於或欲用於無 = 注射器。 π衣置之皮下 堵堵裝置3主要欲用於在該筒身2之第—端51處封 =濟身2。隨後在筒身2中可移動之封堵裝置3包含以下 Ο Ο 該封堵裝置3經調適以用於耗接至柱塞i以便作為-總成回縮至該筒身中。 。亥封堵裝置3經調適以用於在置換流體期間不被推出 於筒身2外。為達成此目的,該封堵裝置3包含第一阻塞 部件b卜且該筒身2之内壁在其第—端51處包含與該等第 一阻塞部件Μ協作之第:阻塞部件(特定言之,阻塞凹槽 b2(H® 1Α'圖1Β及圖1C))’其中該等第—阻塞部件 s等第—阻塞部件b2經調適以用於阻塞封堵裝置3朝 筒身之第一端51之方向的移動(至外部)。 封堵裝置3經調適以用於在該筒身2之第一端處旋 轉固定地置放於筒彡2中。在該狀況下可使用相同阻塞部 件及b2 ’其中該等阻塞部件b 1及b2經調適以用於阻塞 該封堵裝置3繞其中心線之旋轉。 該封堵裝置3經調適以用於在該針頭插入至一目標(未 圖不)中期間不被推動至筒$ 2卜為達成此目的,該封 堵裝置3包含第一鎖定部件vl,且該筒身2之内壁在接近 八第缒51處包含與該等第一鎖定部件vl協作之第二鎖 19 201100135 定部件(特定言之,鎖定凹槽v2(參見圖2、圖3、圖 圖5 ))’其中該等第一鎖定部件vl及該等第二鎖定部件 經調適以用於封堵裝置3朝該筒身之第二端52之方 動(至内部)的鎖定。 移 一方面,該封堵裝置3經調適以用於在該針頭插入 一目標中期間不移動至該筒身2内部。為達成此目的,誃 等鎖疋部件vl形成與鎖定部件v2之形扣合連接(^啦 closed C〇nnection ),從而引起一鎖定。 〇啦 另一方面,該封堵裝置3在該針頭已插入至一目標中 之後必須可回縮至該筒身2中。關於此要求該等鎖 件Vl與該等鎖定部件V2需要加以解鎖。 ° 直至剛好在將該柱塞1耗接至該封堵裝置3之前或之 後方發生解鎖。為達成此目的,用於將該柱塞i耗接至該 封堵裝置3之第-耦接部件kl及第二耦接部件U亦; 適以用於解鎖該等第—鎖定部件Η與該等第二鎖定部“2 之鎖定。 圖2至圖5展示該等第二麵接部件匕已配置於上面亦 已配置有該封堵裝置3之第一錯定Λ 之$鎖疋部件W的結構上的實施 例0 近最大穿透之結尾之柱塞!,但其中該柱塞 1尚未與彈性地連接至該封堵裝置3之鎖33接觸。 該鎖33具備搞接構件k2,該等轉接構件匕在此實施 例中配備有突出倒鉤3 4。 、 該柱塞1之第-端61具㈣接構件ki,該等耗接構件 20 201100135 k1在此實施例中配備右田 34協作之突出硬質倒鉤^於與該彈性鎖33上之輪接倒鉤 圖3展示柱塞2之進 已使該封堵裝置3肩專硬質倒鉤12The view of G column is not the same as that shown in Fig. 27D, which has the retreat of the bandit king and the needle is pulled into the inside of the barrel; Figure 28 shows the vertebral state of Fig. 22 A perspective view of the same body, in which one of the barrels is cut. P is for revealing the distal end of the plunger; FIG. 29 is a perspective view of the plunger; Plunger I: an enlarged partial perspective view of one of the distal ends of the plunger, including the buckle edge of the plug; A perspective view of another enlarged portion of the distal end of the plug; and a cross-sectional view of the syringe of the first embodiment of the present invention, wherein the plunger is in a different processing step within the body and body. [Embodiment] The present invention will be described with reference to the accompanying drawings in which: FIG. 17 201100135 Figure 1 is an exploded perspective view of a hypodermic syringe and showing a plunger 丨 (also known as a piston), a barrel 2 (also known as a reservoir or housing), and a occlusion device 3 (also known as a needle holder) Or pin seat) and needle device 4. The barrel 2 has a generally cylindrical inner wall and includes a flange 21 at the second end 52 for holding the hypodermic syringe and a first end 51 opposite the barrel. The occlusion device 3 is adapted to block the first body of the barrel 2, wherein the occlusion device 3 is provided with a through-opening 31 that is connected to the adapter for coupling to The nozzle W of the needle device 4 is closed, and the second side of the nozzle 32 is provided with a second __ A. The plunger I can be movably placed in the barrel 2 when the barrel 2 is The fluid is pushed out of the barrel, and the A. ^, the plunger 1 is at least partially protruded from the barrel at the second end 52 of the barrel. The first -... is entered in the barrel 2. The V-pair of the plunger: the two ends 62 of the plug 1 include a pressing portion u. The first coupling member 协作 of the first coupling member k2 of the plunger cake 61 cooperates with the second coupling member k2 for adaptation of the coupling member 3 In the barrel 2, the assembly of the plunger 1 and the occlusion device 3 is moved toward the mountain of the barrel 2. The occlusion device 3 is in the condition 2 in the case of the barrel 2 such that the occlusion device 3 (as the case includes - the needle J moves, the barrel), wherein the occlusion device 3 can be returned Retracted to the first end 51 sealingly adjacent to the barrel 2 at least in the barrel 2 18 201100135 The occlusion device 3 is provided with a nozzle 32, wherein the "adapted for - and - standard needle or needle device 4 lightly connected, external quasi-needle or needle device 4 is generally suitable or intended for non-injector syringes. π-suited subcutaneous occlusion device 3 is mainly intended to be used at the first end 51 of the barrel 2 Body 2. The occlusion device 3, which is then movable in the barrel 2, comprises the following: The occlusion device 3 is adapted for consuming to the plunger i for retraction into the barrel as an assembly. The clogging device 3 is adapted for not being pushed out of the barrel 2 during replacement of the fluid. To achieve this, the occlusion device 3 comprises a first blocking member b and the inner wall of the barrel 2 is at its - End 51 contains the first blocking element in cooperation with the first blocking member (blocking element b2 (H® 1Α' Figure 1Β and Figure 1 C)) 'where the first - blocking member s, etc. - the blocking member b2 is adapted to block the movement of the occlusion device 3 in the direction of the first end 51 of the barrel (to the outside). Adapted for rotationally fixed placement in the cartridge 2 at the first end of the barrel 2. In this case the same blocking member and b2 ' can be used, wherein the blocking members b 1 and b2 are adapted for use Blocking the rotation of the occlusion device 3 about its centerline. The occlusion device 3 is adapted for not being pushed to the cartridge during insertion of the needle into a target (not shown) for this purpose. The occlusion device 3 includes a first locking member v1, and the inner wall of the barrel 2 includes a second lock 19 201100135 in cooperation with the first locking members v1 near the eighth 缒 51 (specifically, Locking groove v2 (see FIG. 2, FIG. 3, FIG. 5)) wherein the first locking members v1 and the second locking members are adapted for the occlusion device 3 toward the second end of the barrel Locking of the motion of 52 (to the inside). On the one hand, the occlusion device 3 is adapted for insertion in the needle During the target period, it does not move to the inside of the barrel 2. To achieve this, the locking member v1 forms a snap-fit connection with the locking member v2, thereby causing a lock. On the other hand, the occlusion device 3 must be retractable into the barrel 2 after the needle has been inserted into a target. It is required that the lock member V1 and the locking members V2 need to be unlocked. The unlocking occurs just before or after the plunger 1 is consuming the damming device 3. To achieve this, the first coupling member k1 for consuming the plunger i to the occluding device 3 and The second coupling member U is also adapted to unlock the first locking member and the second locking portion "2". 2 to 5 show the structure of the second surface joint member 匕 which has been disposed on the structure of the first locking member W of the damming device 3 The plunger at the end!, but wherein the plunger 1 has not yet been in contact with the lock 33 that is resiliently connected to the occlusion device 3. The lock 33 is provided with a engaging member k2 which is provided with a protruding barb 34 in this embodiment. The first end 61 of the plunger 1 has a (four) connecting member ki, and the consumable members 20 201100135 k1 are equipped with a protruding hard barb of the right field 34 cooperated with the wheel on the elastic lock 33 in this embodiment. Hook Figure 3 shows that the plunger 2 has made the occlusion device 3 shoulder hard barb 12
Mu 輕接倒釣34 ·弯曲至内部,立卜" 在此方向上預偏壓至 β 八中遠鎖33 彎曲至S °㈣’該等鎖定㈣35將已 丨逆使件4專鎖定部件vi盥 間的較被解鎖之程度, 封 件V2之 之第二端52之方 f現該封堵裝置3朝該筒身2 Ο <万向移動的可能性。 圖4展示該柱塞1$;隹__ 第一端61卜 之進—步穿透,#中在該柱塞^ 之硬質倒鉤12已遠遠地穿透至該鎖33中,以 付“、堵裝置3之耗接倒釣34已稍微再次彈回。該 接倒釣3 4喃合至马莖游知 π 該寺硬質倒鉤12上,因而,該柱塞 該封堵裝置3連接以用於能夠-起朝該筒身2之第二端52 之方向滑動。 圖5展不歸因於此連接,該柱塞1與該封堵裝置3之 、%成朝4筒身2之第二端5 2之方向稍微回縮。 圖2至圖5亦展示用於將密封環(圖上未示)置放於 该筒身2之第一端5丨處的圓周凹槽%。舉例而言該密封 壞確保流體無法越過該封堵裝置滲漏。 圖2至圖5亦展示該柱塞1之第一端61之形狀。不僅 該等硬質倒鈎12附接於該末端處,而且填充體13之第— 端91亦附接於該末端處。 在大體扁平填充體13之俯視圖中,其自其第一端91 包含—端桿(end stem) 14、一第一輪廓15,該第一輪廊 21 201100135 15朝向其最終尖端16而直徑增加,在該封堵裝置3中談 最終尖端16鄰接該貫通口 31之邊緣。歸因於具有該填: 體13之柱塞1穿透於該封堵裝置3中(尤其穿透於在該封 堵裝置3之全寬上延伸且由該鎖%之可撓性支腳在任 上接臨的凹穴中及貫通口 31中),有效地限制剩餘容積。 進-步朝向該填充體13之背對第一端%的第 92’該第二端92包含一第二輪廓17。輪廓17經調適以用 於在柱塞1之最大穿透的情形下使該填充體13以與該貫通 口 31之輪廓37相距之最小距離鄰接該貫通口”之輪广 37,以用於限制剩餘容積。 邪 更進一步朝向該填充體13之第二端92,存在—錐 心其置換位於該封堵裝置之貫通口 31中之喷嘴Μ之位 置處的最終剩餘容積。 圖1展不該填充體13之透視圖。歸因於該封堵求置3 之形狀,將填充體13設計為扁平的,在該封堵裝置:之开》 狀中’該封堵裝置3之背對噴嘴32之末端處之貫通口 ^ 為大體扁平矩形的。 該封堵裝置3中之貫通口 31之高度與位於在該筒身2 之中心線之任一側上之一距離處的最終點16之間的距離大 體對應。 人 1封堵m巾之貫通口 31之寬度與該騎填充構件 13之寬度大體對應。 圖2展示柱塞1之一情形,其中該柱塞確實接近於轉 接至㈣堵裝置3,但其中料塞1可仍個別地回縮至該筒 22 201100135 身2中。該情形可與流體可藉由朝該筒身2之第二端之 方向滑動柱塞i吸入至筒身2中而針頭裝置4之 至流體中的情形對應。 # Ο 〇 為了吸取流體,該柱塞i應延伸至該筒身中達使得該 柱塞1剛好尚未輕接至該封堵裝置3之程度。為了防止在< 此動作中朝該筒身之第一端51之方向意外地進—步推動該 柱塞1 (因而’該柱塞i將輕接至該封堵裝置3),該柱塞i 在接近該柱塞1之第二端62處具備_制動機構7。 圖6展示連接至該柱塞}之制動機構7,該機構處於第 —情形中。在該情形中,該柱塞i能夠在該筒身2中朝該 筒身2之第-端51之方向移動的距離受限,因為該制動: 構7之末端71抵靠凸緣21(參見圖7)。該移動因此限於 使传該柱塞i無法使其自身耗接至該封堵裝置3之程度(參 見圖2 )。採用此情形作為開始點,可吸取流體。 乂 -圖8展示置放於該柱塞上之制動機構7,該機構處於第 :情形中。在此情形中’該柱塞!能夠在該筒身2中朝該 =身2之第-端51之方向移動的距離受限,因為該制動機 構7之末端72抵靠凸緣21 (參見圖9)。當該柱塞丄實際 上抵靠該凸緣時,最大可能容積已被置換,且該柱塞!: 使其自身搞接至該封堵裝置3(參見目4)。採用此情形作 ^開始點’該柱塞i與該封堵裝置3之總成可回縮至 身中(參見圖5 )。 ^ 圖10A展示導引裝置8,該等導引裝置8使其第一端可 撓性地連接至該凸、緣2卜該導引裳置8之背對第—端之第 23 201100135 二端包含形成導引之鬆動端81。在—項實施例中,該形狀 可包含一叉狀結構82。 圖10B展示該叉狀結構82之經調適以用於導引該柱塞 i之肋U3至H6(參見圖n)中之—者的又狀槽土 對於該柱塞1之此導引,需要使該等導引襞置8之鬆 動端81 it到-規定位置’其中該柱塞之所要肋114、 置放於該叉狀槽83中。 為了達成此情況’該等導引裝置8包含第—連接構件, 其中與其協作之第二連接構件(例如)已配置於該筒身2 之凸緣21處。第-及第二連接構件經調適以用於該鬆動端 8 1與該凸緣2 1之間的互相連接。 在例示性實施例中,該等導引裝置8包含第一連接構 件倒釣84,其鉤至配置於該凸緣21中之卡孔⑺⑽一 hole ) 85 ° -旦已將該等倒鉤84推動經過該等卡孔^,便 產生其之間的連接。 在-項實施例中,使用兩個導引裝置8來導引該柱塞( 之肋U3至116中之兩者。當該封堵裝置3之背對喷嘴之末 端及該柱塞丨之填充構件13之連接至該封堵裝置之部分不 具有圓柱形設計時,該柱塞1應正確地定向以便使該柱塞i 之填充構件13正_地進人該封堵裝置3。該兩個導引裳置 8:調適以用於界定該柱塞丨之正確位置。該柱塞i與該封 者衣置3之間的正確定向亦為必要的,以使得論構件η 及k2能夠正確地耦接。 除了上文描述之該等導弓丨裝置8之魏(即充分地導 24 201100135 引該柱塞1及在續铭 it 2| ^ w 〇 中正確地定向該柱塞 導引裝置8具有第三功能1,)之外’该 端52之方向之移動 ㈣身2之第二 件19而達成定界,”移:由向餘塞1提供移動限制構 身2之第二端52之二動限制構件19在杈塞1朝該筒 -部分。 之方向移動時最終抵靠料h構件8之 已將鄰接凸輪19 (參見圖12)配 在例示性實施例中 置為移動限制構件。 〇Mu lightly reversed fishing 34 · Bend to the inside, Lib " Pre-biased in this direction to β 八中远锁33 Bend to S ° (4) 'The locks (4) 35 will have the hiccups 4 special locking parts vi盥The degree of unlocking between the two ends of the second end 52 of the seal V2 is now the possibility that the occluding device 3 moves toward the barrel 2 < Figure 4 shows the plunger 1$; 隹__ first end 61 of the step-by-step penetration, # in the plunger ^ the hard barb 12 has penetrated far into the lock 33 to pay " The slamming device 34 has been slightly bounced back again. The squid 3 4 is spliced to the horse stalk π the hard barb 12 of the temple, and thus the plunger is connected to the occlusion device 3 For slidable in the direction of the second end 52 of the barrel 2. Figure 5 is not due to this connection, the plunger 1 and the occlusion device 3 are in the direction of the 4 barrel 2 The direction of the two ends 5 2 is slightly retracted. Figures 2 to 5 also show a circumferential groove % for placing a seal ring (not shown) at the first end 5丨 of the barrel 2. The seal is broken to ensure that fluid cannot leak past the occlusion device. Figures 2 to 5 also show the shape of the first end 61 of the plunger 1. Not only are the rigid barbs 12 attached to the end, but also filled The first end 91 of the body 13 is also attached to the end. In a top view of the generally flat filler body 13, it includes an end stem 14 from its first end 91, a first contour 15, which is One round gallery 21 201100135 15 increases in diameter towards its final tip 16, in which the final tip 16 abuts the edge of the through opening 31. The plunger 1 having the filling body 13 penetrates the occluding device 3 Medium (especially penetrates into the recess extending in the full width of the occlusion device 3 and in the adjacent access hole 31 by the flexible foot of the lock), effectively limiting the remaining volume. The step is toward the 92nd' of the first end% of the filling body 13 and the second end 92 comprises a second contour 17. The contour 17 is adapted for use in the case of maximum penetration of the plunger 1 The filling body 13 abuts the wide opening 37 of the through opening "with a minimum distance from the contour 37 of the through opening 31 for limiting the remaining volume. Further, toward the second end 92 of the filling body 13, there is a cone which replaces the final remaining volume at the position of the nozzle 中 in the through opening 31 of the occluding device. Figure 1 shows a perspective view of the filler body 13. Due to the shape of the plugging device 3, the filling body 13 is designed to be flat, in the opening of the blocking device: the through opening of the blocking device 3 opposite the end of the nozzle 32^ It is generally flat rectangular. The height of the through opening 31 in the occluding device 3 substantially corresponds to the distance between the final point 16 at a distance on either side of the center line of the barrel 2. The width of the through opening 31 of the person 1 to seal the m towel substantially corresponds to the width of the riding filler member 13. Figure 2 shows a situation in which the plunger 1 is indeed close to being transferred to the (four) blocking device 3, but wherein the plug 1 can still be individually retracted into the barrel 22 201100135 body 2. This situation may correspond to the situation in which the fluid can be drawn into the barrel 2 by sliding the plunger i toward the second end of the barrel 2 and the needle device 4 into the fluid. # Ο 〇 In order to draw fluid, the plunger i should extend into the barrel to such an extent that the plunger 1 has not just been lightened to the occluding device 3. In order to prevent the plunger 1 from being accidentally pushed in the direction of the first end 51 of the barrel in the < this action, the plunger 1 will be lightly connected to the occlusion device 3, the plunger i is provided with a brake mechanism 7 near the second end 62 of the plunger 1. Figure 6 shows the brake mechanism 7 connected to the plunger}, which is in the first case. In this case, the distance that the plunger i can move in the barrel 2 in the direction of the first end 51 of the barrel 2 is limited because the brake: the end 71 of the structure 7 abuts against the flange 21 (see Figure 7). This movement is therefore limited to the extent that the plunger i cannot be self-fed to the occlusion device 3 (see Figure 2). With this situation as a starting point, fluid can be drawn.乂 - Figure 8 shows the brake mechanism 7 placed on the plunger, which is in the first case. In this case 'the plunger! The distance that can be moved in the barrel 2 in the direction of the first end 51 of the body 2 is limited because the end 72 of the brake mechanism 7 abuts against the flange 21 (see Fig. 9). When the plunger 丄 actually abuts the flange, the maximum possible volume has been replaced and the plunger! : Attach itself to the occlusion device 3 (see item 4). In this case, the assembly of the plunger i and the occluding device 3 can be retracted into the body (see Fig. 5). Figure 10A shows a guiding device 8 having its first end flexibly connected to the convex, rim 2, the back end of the guiding skirt 8 at the end of the 23rd 201100135 A loose end 81 is formed that forms a guide. In the embodiment, the shape may comprise a forked structure 82. Figure 10B shows the adjustment of the fork structure 82 for guiding the slats of the ribs U3 to H6 (see Figure n) of the plunger i for the guiding of the plunger 1 The loose end 81 of the guiding device 8 is brought to a predetermined position where the desired rib 114 of the plunger is placed in the forked groove 83. In order to achieve this, the guiding means 8 comprise a first connecting member, wherein a second connecting member cooperating therewith, for example, has been arranged at the flange 21 of the barrel 2. The first and second connecting members are adapted for interconnection between the loose end 81 and the flange 21. In an exemplary embodiment, the guiding means 8 includes a first connecting member back fishing 84 that is hooked to a card hole (7) (10) disposed in the flange 21 at a level of 85 ° - the barbs 84 have been Pushing through the card holes ^ creates a connection between them. In the embodiment, two guiding devices 8 are used to guide the plunger (both of the ribs U3 to 116. When the blocking device 3 is facing away from the end of the nozzle and the filling of the plunger) When the portion of the member 13 that is connected to the occlusion device does not have a cylindrical design, the plunger 1 should be properly oriented so that the filling member 13 of the plunger i enters the occluding device 3 positively. Guide skirt 8: adapted to define the correct position of the plunger. The correct orientation between the plunger i and the closure 3 is also necessary to enable the components η and k2 to be correctly Coupling. In addition to the above-described guide bow device 8 (i.e., fully guide 24 201100135 leads the plunger 1 and in the continued it 2 | ^ w 正确 correctly orients the plunger guide 8 With the third function 1,), the movement of the direction of the end 52 (four) of the second piece 19 of the body 2 is delimited, "shift: by providing the second end 52 of the movement limiting body 2 to the ember 1 The second movement restricting member 19 finally abuts the abutment cam 19 (see Fig. 12) when the dam 1 is moved in the direction of the barrel-portion. Exemplary embodiment illustrated embodiment is set to limit the movement member. Billion
2位置中’肖皮下注射器具有—大體長形狀。已知 L有此長度-厚度比之產品被(例如)二等分 效地執行處理廢料。圖13A 、更有 “ 81 13為達成此目的展示該柱塞1之削 弱物112 ’該削弱物i i 2使得有 史仔有可月b減少該皮下注射器之長 包3該柱塞卜包括該針頭裝置4之封堵褒置3及回 縮於》亥筒身2中之鄰接凸輪19的總成鄰接該等導引裳置8 時削弱物112剛好位於筒身2外部、接近凸緣2ι。在此 情形下’該柱塞之突出部分可簡單地使用極小手動力與該 皮下注射器斷開(參見圖14)。 _圖15展示用於投予較大體積之流體之皮下注射器之例 不性實施例的筒身2及封堵裝置3。在此實施例中,該封堵 裝置3與如迄今為止描述之封堵裝置3相同。根據此情況, "玄筒身2至;在其第一端51處(尤其在置放於該筒身2中 之封堵裝置3之第一端38與第二端39之間)亦相同地加 以叹叶。為了增加該筒身2之容積,該筒身2之内徑d2 (至 夕除了該筒身2之第一端51處之封堵裝置3的位置之外) 25 201100135 6又s十成大於s亥筒身2之内徑d 1。因為該封堵裝置3相同, 所以在本文中保持本發明之特性化特徵,其中有可能將標 準尺寸之針頭置放於具有對應標準化尺寸的喷嘴32 (其為 封堵裝置3之一部分)上,以使得在投予流體之後該針頭 可儲存於該筒身中。 應注意,該筒身2之具有直徑d2之加寬部分之中心線 亦可相對於具有直徑dl之接近第一端S1之筒身2之中心 線平行地移位。 圖16展示亦用於投予較大體積之流體之皮下注射器之 實施例的筒身2及封堵裝置3。在該實施例中該封堵裝置 3與如迄今為止描述之封堵裝置3不同。該封堵裝置之直 自第-端38考慮朝第二端39之方向增加。在圖“中,: t悝^加:問題’因而達成封堵裝置之圓錐形形狀。铁 ,可使用母-形狀之封堵裝置’只要該放 於該筒身中以使得其可釋放(此係對使 置=放 該筒身2中之要貝裒置4回縮至 為達成此目的,直徑自第—端3 慮朝封堵裝置之第二端39之方向之增加具有恆知38考 為必要的。局部地較微弭 疋過程並非 也较被弱及較急劇之增加亦為允許的。 艮此情況,該筒身2至少在其第一端5 、 置放於該筒身2中之封 處(尤其在 之封堵裝置3之第一端3 s 之間)設計成具有相同輪靡。 與第二端39 具有此不同封堵奘要 圖式t展示,但亦可 了注射器之筒身2雖然未在 之皮下注射器中的筒、;°又计成具有如應用於根據圖15 〜同身2之加寬。 26 201100135 不同封堵裝f 1 徵,其中因此有可能有本發明之相同特性化特 準尺寸的嘴嘴32( ;| :之針頭置放於具有對應標 在投予…後該針 直徑:處之’:5 置…線可相對於具有 圖17“ 缚身2之中心線平行地移位。 為根據本發明之皮下注射器之又一 Ο ,分解透視圖,且展示柱塞201 (亦稱為活塞)、=: (亦輪為貯液器或殼體)、封堵裝置2G3 (亦稱為針頭支座 或錯座)及針頭裝置204。 3亥筒身202具有大體圓㈣内帛,且包含在第二端252 處之用於固持該皮下注射器之凸緣221及背對該筒身之第 二端的第一端25 1。 該封堵裝置203經調適以用於封堵該筒身2〇2之第一 端251 ’其中該封堵裝置203具備一貫通口 231,該貫通口 231向外地連通於經調適以用於耦接至一針頭裝置4之喷嘴 〇 232中。5亥封堵裝置203在一背對噴嘴232之側處包含第二 辆接構件k202。 可將柱塞201可移動地置放於筒身202中以用於在穿 透至該筒身202中時將流體推出於該筒身外,其中該柱塞 201在筒身之第二端252處至少部分地突出於筒身202外。 該柱塞201之第一端261插入於筒身202中。該柱塞之背 對第一端261之第二端262包含一按壓部分211。該柱塞之 第一端261包含與第二耦接構件k202協作之第一耦接構件 27 201100135 k201,其中第—搞接構件k201及第二耦接構件k202經調 適以用於該柱塞2G1與該封堵裝£ 203之叙接,以便在該 筒身2〇2中朝該筒| m之第二端⑸之方向移動該柱塞 2〇1及該封堵裝置203之總成。 與上文參看圖1描述之例示性實施例相反,該等第一 柄接構件k2(H為大體圓形對稱的。因而,該活塞加不再 需要與該封堵裝置2G3對準,且因此不旋轉以地固持於 該筒身202中。 ,圖18A及圖18B展示與圖〖A及圖ib相當之視圖,不 過當然用於該又-例示性實施例。圖18A之側視圖與圖⑽ 之側視圖大體垂直。 圖19A至圖19D展示將該柱塞2〇1搞接至該封堵裝置 2〇3且將該封堵裝置2G3回縮至該筒身2()2中之過程 個步驟。 圖19A展示接近最大穿透之結尾之柱塞2〇丨,但其中坌 尚未與彈性地連接至該封堵裝置2G3之鎖234接觸。、/、 該鎖234具備㈣構件,該等耗接構件在此實施例中 配備有突出倒鉤。 該柱塞2〇1之第一端212具備環形耗接構件該等環 形耦接構件在此實施例中配備有用於與該彈性鎖上 倒鉤234協作之圓周硬質搭扣邊緣。 ^ ^ /不心,卉甲該搭扣 緣212已使該封堵裝置加之純倒鉤234料至内部 其中該鎖在此方向上預偏M至最大量。同時該等鎖定 28 201100135 件或倒鉤235 ϋ# ρ _ οι* y 相關鎖部達使得該㈣定部件235與 凹槽之間的鎖定被解鎖之程度1中實現該封堵 置2〇3朝該筒身2〇2第- 弟一端之方向移動的可能性。 圖1 9 C展示該知當ο Λ, 201之第山“主塞201之進-步穿透’其中在該柱塞 之第〜之搭扣邊緣212已遠遠地穿透至該鎖中以 *〜封堵裝置203之耗接倒鉤234已稍微再次彈回。該 等耦接倒鉤234嚙人黾兮笙枚4皇t 。人 Π亥4搭扣邊緣212上,因而,該柱 Ο Ο 土 该封堵裝置203連接以用於能夠一起朝該筒身2〇2 之第二端之方向滑動,如圖19D中展示。 此外,置放於此實施例之筒身中(接近該筒身之末端) 的封堵裝X 203之部分具備一徑向地向外延伸之圓周唇緣 或肋,其中該唇緣與該封堵裝置整體地形成。該唇緣確保 該封堵裝置與該筒身之内壁之間的足夠密封,而無需對達 成此目的必要的額外密封元件。 對柱塞201朝筒身202之第二端252之方向之移動定 界。藉由在接近該第二端252處向該筒身202提供鄰接隆 脊219而達成定界,該隆脊在該柱塞201朝筒身202之第 二端252之方向之移動時將最終阻塞該柱塞201之通過。 在該例示性實施例中,該鄰接隆脊219 (參見圖20α )於該 筒身202内部配置成接近其第二端252。 圖20Β展示柱塞201之削弱物’該削弱物使得有可能 減少該皮下注射器之長度。當包含該柱塞20 1、包括該針頭 裝置204之封堵裝置203之總成回縮至該筒身202中時, 該削弱物鄰接該鄰接隆脊219。在此情形下,該柱塞201之 29 201100135 突出部分可簡單地使用較小手動力與該皮下注射器斷開 (參見圖20C )。 應注意,該柱塞20 1之前側可具備一橡膠密封件μ], 其可置放於為達成此目的配置於該柱塞上之圓周凹槽 上。 此外,該柱塞201之具有搭扣邊緣212之前側具備— 侧向延伸之開口,在注射模製過程中製造該柱塞期間,模 核被傳遞經過該開口以用於使該搭扣邊緣212後的空間(該 等耦接倒鉤2 3 4嚙合至該空間中)成形。 又一例示性實施例展示於圖21至圖31中。在此例示 性實施例中’針頭支座在大體由參考數字31〇指代之皮下 注射器之喷嘴3 13上的外側。 該注射器310包含一圓柱形筒身312,其具有用於可拆 卸地連接至一針頭總成314之圓錐形遠端部分313。該針頭 總成3U包含一針頭316’該針頭316如圖%中展示固定 地置放於錨座3 1 8 4。該錨座3 1 8經調適以用於耦接至 可移動地置放於該筒身312中之活塞或柱塞32〇,其中藉由 該錫座318而在該柱塞32。在脫離筒纟312之近端方^上 回縮時將該針頭316拉動至該筒身312中。 耗接機構包含具有纟近端方向上終止的兩個或兩個以 上可撓性支腳322之錨座318,該等可撓性支腳322具有面 朝外之搭扣①件324,該等搭扣元件324能夠喷合該柱塞 320之遠端329中之搭扣邊緣326以用於形成一搭扣連接。 忒皮下注射器2 1 〇使使用者能夠以安全且精確之方式 30 201100135 投予注射液’其中極大減少針頭刺傷之風險。如圖23及圖 24中展示’該針頭總成314包含一罩蓋33〇,其可推動靠 在該筒身之圓錐形端313上以用於與該圓錐形端313之摩 擦界定及可拆卸連接。該錨座318可拆卸地且同軸地安裝 於該罩蓋中,且該針頭3 16經由螺紋連接固定地連接至該 錨座318。以已知方式,該針頭之遠端具備用於將該針頭戳 入身體中之尖銳刺入部分(圖上未示)。 如圖23及圖24中展示,該罩蓋33〇包含一縱向通道In the 2 position, the 'Shapi lower syringe has a substantially long shape. It is known that L having such a length-thickness ratio product is subjected to processing waste by, for example, quintile. Figure 13A, and further "81 13 shows the weakened object 112 of the plunger 1 for this purpose. The weakened material ii 2 makes it possible to reduce the long bag 3 of the hypodermic syringe. The plunger includes the needle device. The blocking device 3 of 4 and the assembly of the abutting cam 19 retracted in the "Heel body 2" abut the guiding skirts 8 when the weakening 112 is located just outside the barrel 2, near the flange 2ι. In this case, the protruding portion of the plunger can be easily disconnected from the hypodermic syringe using minimal hand power (see Figure 14). Figure 15 shows an example of a hypodermic syringe for administering a larger volume of fluid. The barrel 2 and the occlusion device 3. In this embodiment, the occlusion device 3 is identical to the occlusion device 3 as described so far. According to this situation, "Xuan barrel 2 to; at its first end 51 is also singed in the same manner (especially between the first end 38 and the second end 39 of the occlusion device 3 placed in the barrel 2). To increase the volume of the barrel 2, the barrel The inner diameter d2 of 2 (except for the position of the occlusion device 3 at the first end 51 of the barrel 2) 25 201100135 6 s ten is greater than the inner diameter d 1 of the s-tube body 2. Since the occluding device 3 is the same, the characteristic features of the invention are maintained herein, wherein it is possible to place a standard sized needle in a corresponding standardized size a nozzle 32 (which is part of the occlusion device 3) such that the needle can be stored in the barrel after administration of the fluid. It should be noted that the barrel 2 has a centerline of the widened portion of the diameter d2 It can also be displaced in parallel with respect to the centerline of the barrel 2 having a diameter dl close to the first end S1. Figure 16 shows a barrel 2 and an embodiment of an embodiment of a hypodermic syringe that is also used to deliver a larger volume of fluid. The blocking device 3. In this embodiment the blocking device 3 is different from the blocking device 3 as described so far. The blocking device is increased from the first end 38 in the direction of the second end 39. Medium, t悝^ plus: problem 'Therefore the conical shape of the occlusion device is achieved. Iron, a female-shaped occlusion device can be used as long as it is placed in the barrel so that it can be released (this is the pair of squatting/retracting the shovel 4 in the barrel 2 to achieve this) OBJECTIVE: The increase in diameter from the end-to-end 3 to the second end 39 of the occlusion device is necessary for the Hengzhi 38 test. The local micro-small process is not weaker and more sharply increased. In this case, the barrel 2 is designed, at least at its first end 5, in the seal placed in the body 2 (especially between the first ends 3 s of the occlusion device 3). The same rim. With the second end 39 having this different sealing, the figure t is shown, but the barrel 2 of the syringe, although not in the subcutaneous syringe, can also be counted as Figure 15 ~ Widening of the same body 2. 26 201100135 Different sealing devices f 1 sign, wherein it is possible to have the same characteristically sized mouth 32 of the present invention ( ; | : needle placed in the corresponding standard After casting, the diameter of the needle: at the position of '5' can be parallel to the center line having the body 2 of Figure 17 A further perspective view of a hypodermic syringe according to the present invention, an exploded perspective view, and showing a plunger 201 (also known as a piston), =: (also a reservoir or housing), and a occlusion device 2G3 (also The needle hub 202 has a substantially round (four) inner bore and includes a flange 221 at the second end 252 for holding the hypodermic syringe and the tube a first end 25 1 of the second end of the body. The occlusion device 203 is adapted to block the first end 251 ′ of the barrel 2 〇 2 , wherein the occlusion device 203 is provided with a through hole 231 , the through hole The 231 is outwardly coupled to the nozzle bore 232 adapted for coupling to a needle device 4. The 5H plugging device 203 includes a second bridge member k202 at a side opposite the nozzle 232. The plunger can be inserted 201 is movably disposed in the barrel 202 for pushing fluid out of the barrel when penetrating into the barrel 202, wherein the plunger 201 is at least partially at the second end 252 of the barrel Projecting beyond the barrel 202. The first end 261 of the plunger 201 is inserted into the barrel 202. The second side of the plunger is opposite the first end 261 262 includes a pressing portion 211. The first end 261 of the plunger includes a first coupling member 27 201100135 k201 that cooperates with the second coupling member k202, wherein the first engaging member k201 and the second coupling member k202 are adapted For the connection of the plunger 2G1 and the plugging device 203, so as to move the plunger 2〇1 and the plugging in the barrel 2〇2 toward the second end (5) of the tube|m The assembly of device 203. In contrast to the exemplary embodiment described above with reference to Figure 1, the first shank members k2 (H are generally circularly symmetrical. Thus, the piston plus is no longer required to be aligned with the occlusion device 2G3 and thus is retained in the barrel 202 without rotation. 18A and 18B show views equivalent to those of Figs. A and ib, but of course used for the yet-exemplary embodiment. The side view of Fig. 18A is substantially perpendicular to the side view of Fig. (10). 19A to 19D show the steps of the process of engaging the plunger 2〇1 to the occluding device 2〇3 and retracting the occluding device 2G3 into the barrel 2()2. Figure 19A shows the plunger 2〇丨 near the end of the maximum penetration, but wherein 坌 has not been in contact with the lock 234 that is resiliently coupled to the occlusion device 2G3. The lock 234 is provided with (four) members which are provided with protruding barbs in this embodiment. The first end 212 of the plunger 201 is provided with an annular consumable member which in this embodiment is provided with a circumferential rigid snap edge for cooperating with the resilient latch barb 234. ^ ^ / Unfortunately, the buckle rim 212 has caused the occlusion device to be fed with a pure barb 234 to the inside where the lock is pre-biased M to the maximum amount in this direction. At the same time, the lock 28 201100135 or the barb 235 ϋ# ρ _ οι* y the relevant lock portion is such that the lock between the (four) fixed member 235 and the groove is unlocked 1 to achieve the plugging 2〇3 toward The possibility that the barrel 2〇2 is moved in the direction of the first one. Figure 1 9 C shows the knowledge of the ο Λ, 201 of the mountain "the main plug 201 into the step penetration" where the snap snap edge 212 of the plunger has penetrated far into the lock to * The consuming baffle 234 of the occluding device 203 has bounced back slightly again. The coupling barbs 234 are indented by a scorpion 4 4 皇 。. The Π 4 4 4 4 buckle edge 212, thus, the column Ο The occlusion device 203 is coupled for slidable together in the direction of the second end of the barrel 2〇2, as shown in Fig. 19D. Further, placed in the barrel of the embodiment (close to the barrel) Portion of the closure X 203 having a radially outwardly extending circumferential lip or rib, wherein the lip is integrally formed with the occlusion device. The lip ensures the occlusion device and the barrel A sufficient seal between the inner walls of the body without the need for additional sealing elements necessary to achieve this. The movement of the plunger 201 in the direction of the second end 252 of the barrel 202 is delimited by the proximity of the second end 252. Abutment is provided to the barrel 202 by abutting the ridges 219 that are displaced in the direction of the plunger 201 toward the second end 252 of the barrel 202. The passage of the plunger 201 will eventually be blocked. In the exemplary embodiment, the abutting ridge 219 (see Fig. 20a) is disposed inside the barrel 202 proximate to its second end 252. Figure 20A shows the plunger 201 The weakener 'the weakener makes it possible to reduce the length of the hypodermic syringe. When the assembly comprising the plunger 20 1 including the occlusion device 203 of the needle device 204 is retracted into the barrel 202, the weakening The object abuts the abutting ridge 219. In this case, the projection 201 201100135 of the plunger 201 can be easily disconnected from the hypodermic syringe using a small hand power (see Fig. 20C). It should be noted that the plunger 20 1 The front side may be provided with a rubber seal μ] which may be placed on a circumferential groove disposed on the plunger for this purpose. Further, the plunger 201 has a buckle edge 212 on the front side - lateral An extended opening during which the core is transferred during the injection molding process, the core is passed through the opening for space behind the buckle edge 212 (the coupling barbs 243 engage into the space) Forming. Yet another exemplary embodiment shows 21 to 31. In this exemplary embodiment, the needle holder is on the outside of the nozzle 3 13 of the hypodermic syringe, generally designated by reference numeral 31. The syringe 310 includes a cylindrical barrel 312. There is a conical distal portion 313 for removably attaching to a needle assembly 314. The needle assembly 3U includes a needle 316' which is shown fixedly placed on the anchor 3 1 8 4 The anchor block 318 is adapted for coupling to a piston or plunger 32〇 movably disposed in the barrel 312, wherein the plunger 32 is at the plunger 32. The needle 316 is pulled into the barrel 312 as it retracts from the proximal end of the cartridge 312. The consuming mechanism includes an anchor 318 having two or more flexible legs 322 terminating in a proximal direction, the flexible legs 322 having an outwardly facing buckle member 324, such The snap element 324 can spray the snap edge 326 in the distal end 329 of the plunger 320 for forming a snap connection. The subcutaneous syringe 2 1 〇 allows the user to inject the injection solution in a safe and precise manner 30 201100135, which greatly reduces the risk of needle stick injuries. As shown in Figures 23 and 24, the needle assembly 314 includes a cover 33 that can be urged against the conical end 313 of the barrel for frictional definition and detachment with the conical end 313. connection. The anchor seat 318 is removably and coaxially mounted in the cover, and the needle 3 16 is fixedly coupled to the anchor seat 318 via a threaded connection. In a known manner, the distal end of the needle is provided with a sharp piercing portion (not shown) for punctureing the needle into the body. As shown in Figures 23 and 24, the cover 33 includes a longitudinal passage
G 332,該罩蓋可藉由該縱向通道332以緊貼配合之方式置放 於該錨座之遠端部分周圍。該罩蓋界定一密封唇緣338,其 大體防止在錨座318與罩蓋330之間的流體滲漏。如圖25 中展示,該錨座318包含一大體圓柱形遠端部分334 (其具 有一縱向通道336,該針頭316經過該縱向通道3%而附接) 及-由若干可撓性支腳322界定之近端部分。該錯座318 中之通道336之直徑與擰旋至該通冑336巾之針頭之直徑 對應以大體上無餘隙地附接該針頭。錨座通道可因此經設 計以用於使得有可能將不同直徑之針頭置放於其中。'二认 如圖25及圖26中展示’該錨座318自錨座之大體圓 柱形部分向外延伸以用於在進—步在近端方向上延伸至該 若干可撓性支腳之前界定—徑向邊緣339。該若干可挽性^ 腳322在向外定向之搭扣元件則終止且包含向外地定 向之凸輪340,該等凸輪_大致在可撓性切之中途處。 y至圖27D中展示,該等向外定向之凸輪㈣ 已㈣筒身之遠端與該錫座之大體圓柱形部分之間的 31 201100135 罩蓋中直至该錫座及該針頭回縮為止。 在該柱塞之前向移動期間,該錨座之徑向邊緣339將 由一密封唇緣338大體阻# w L & μ Λ _ 篮丨且塞U防止该針頭及該錨座總成移 出該筒身。 圖28至圖30Β展示該柱| 32〇具有一大體圓柱形端 ’、八有在其側上之貫通口 328及在用於將該錨座 之若干可撓性支腳導引於柱塞中之末端處的向内定向之供 應漏斗333。該供應漏斗333之較窄部分之底部處的大體圓 形開口 335界疋用於耦接至該錨座之搭扣元件之搭扣 邊緣326。 在該圓柱形端329之該側中之貫通口 328具有與如圖 17及圖20Α中展不之第二例示性實施例之柱塞之圓柱形端 k201的該側中之貫通口相同的功能。歸因於該開口,有可 能在注射模製過程中整體地製造該柱塞與該圓周搭扣邊緣 326。 如圖22中展示,當該柱塞32〇已置放於其遠端位置中 時,該柱塞320之大體圓柱形遠端329置放於該筒身313 之遠端中。一柱塞密封件346大體防止注射器之滲漏。待 /主射之藥物或其類似者(圖上未示)在筒身3丨2中置放於 該柱塞之密封件與該筒身之遠端之間。 當使用時’一抽吸針頭(圖上未示)藉由將一習知針 頭置放於該喷嘴上而置放於該注射器310上。該抽吸針頭 可置放於待注射之流體中且待注射之流體可藉由將柱塞 320回縮而吸入至該筒身中。此處應注意,在第一及第二實 32 201100135 =二抽吸針頭並非為必要的,且為了完全填充該注 射該流體,可使用相同習知針頭。 隨後,移除該習知針頭,且如圖23及圖24中展亍 針頭總成314置放於爷饩| Υ展不之 μ 靖身313之喷嘴上。在已投予藥物 / 柱塞之持續移動確保該遠端328如圖27Α中展干 钟广 方向移動。當進-步推動該柱塞時, ^座之可撓性支腳34G如圖咖中展示向内料,以便 Ο Ο 身Π該柱塞…326中。當該柱塞已完全推動至該筒 身中時,如圖27C中展示,兮投4 同 緣326晋於田 下料扣元件324越過該搭扣邊 亦使”:,該等可撓性支腳能夠再次稱微鬆他, 方=324㈣0挽性邊緣咖下 叙接° 27D中展不。以此方式,該錦座主動地且有效地 耦接至該柱塞320。 ^双地 該等凸輪340防止該錯座及該針頭移動至該筒身之内 # (例如,在注射„將針頭插人至病人G 332, the cover can be placed around the distal end portion of the anchor by the longitudinal passage 332 in a snug fit. The cover defines a sealing lip 338 that substantially prevents fluid leakage between the anchor 318 and the cover 330. As shown in Figure 25, the anchor 318 includes a generally cylindrical distal end portion 334 (having a longitudinal channel 336 through which the needle 316 is attached) and - by a plurality of flexible legs 322 Define the proximal part. The diameter of the passage 336 in the wrong seat 318 corresponds to the diameter of the needle screwed to the ventilator 336 to attach the needle substantially without clearance. The anchor channel can thus be designed for making it possible to place needles of different diameters therein. As shown in Figures 25 and 26, the anchor 318 extends outwardly from the generally cylindrical portion of the anchor for defining before the advancement extends in the proximal direction to the plurality of flexible legs. - radial edge 339. The plurality of selectable legs 322 terminate in the outwardly oriented snap elements and include outwardly oriented cams 340 that are generally midway through the flexible cut. y to Figure 27D, the outwardly oriented cams (4) have been in the 31 201100135 cover between the distal end of the (four) barrel and the generally cylindrical portion of the tin seat until the tin seat and the needle are retracted. During the forward movement of the plunger, the radial edge 339 of the anchor will be substantially blocked by a sealing lip 338 # w L & μ Λ _ basket and the plug U prevents the needle and the anchor assembly from moving out of the barrel body. 28 to 30B show that the column | 32 has a large cylindrical end ', eight has a through opening 328 on its side, and is used to guide a plurality of flexible legs of the anchor to the plunger An inwardly directed supply funnel 333 at the end. A generally circular opening 335 at the bottom of the narrower portion of the supply funnel 333 is for coupling to the snap edge 326 of the snap element of the anchor. The through opening 328 in the side of the cylindrical end 329 has the same function as the through opening in the side of the cylindrical end k201 of the plunger of the second exemplary embodiment as shown in Figs. . Due to the opening, it is possible to integrally manufacture the plunger and the circumferential buckle edge 326 during the injection molding process. As shown in Fig. 22, the generally cylindrical distal end 329 of the plunger 320 is placed in the distal end of the barrel 313 when the plunger 32 is placed in its distal position. A plunger seal 346 generally prevents leakage of the syringe. The drug to be/mainly shot or the like (not shown) is placed in the barrel 3丨2 between the seal of the plunger and the distal end of the barrel. When in use, a suction needle (not shown) is placed on the syringe 310 by placing a conventional needle on the nozzle. The aspiration needle can be placed in the fluid to be injected and the fluid to be injected can be drawn into the barrel by retracting the plunger 320. It should be noted here that the first and second actual 32 201100135 = two aspiration needles are not necessary, and in order to completely fill the injected fluid, the same conventional needle can be used. Subsequently, the conventional needle is removed, and as shown in Figs. 23 and 24, the needle assembly 314 is placed on the nozzle of the 饩 饩 313 313 313 313. Continued movement of the administered drug/plunger ensures that the distal end 328 moves in the direction of the clock in Figure 27. When the plunger is pushed further, the flexible leg 34G of the seat is shown as being inwardly shown in the coffee machine so as to be in the plunger 326. When the plunger has been fully pushed into the barrel, as shown in Figure 27C, the same edge 326 is raised by the field fastener element 324 over the buckle side to make ":" The foot can be said to be slightly loose, and the square = 324 (four) 0 is the edge of the edge. The 27D is not displayed. In this way, the pedestal is actively and effectively coupled to the plunger 320. 340 prevents the wrong seat and the needle from moving into the barrel # (for example, injecting „ inserting a needle into a patient
I示,當將該錫絲接至該柱塞時,該等凸輪34〇已移I 中,如圖㈣中展示。以此方式,^頭回縮至該筒身 -射器之筒身内以用於該皮下心:安 =於該皮下 和裔之文全運輸及拋辛。 上文提及之步驟中之每-者亦展示於圖31中, 包括上文描述以說明本發明之 不限制本發明之範嘴。根據上文之解之操作且並 神與範略内的許多變化將為專家所顯而易本發明之精 33I shows that when the tin wire is attached to the plunger, the cams 34 are moved into the I, as shown in Figure (4). In this way, the head is retracted into the barrel of the barrel-injector for the subcutaneous heart: An = in the subcutaneous and the essay is fully transported and thrown away. Each of the above-mentioned steps is also shown in Figure 31, including the above description to illustrate the invention without limiting the scope of the invention. According to the above solution, and many changes in God and Van Gogh will be obvious to the experts.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW98120786A TW201100135A (en) | 2009-06-19 | 2009-06-19 | Hypodermic syringe with retractable needle |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW98120786A TW201100135A (en) | 2009-06-19 | 2009-06-19 | Hypodermic syringe with retractable needle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW201100135A true TW201100135A (en) | 2011-01-01 |
Family
ID=44836476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW98120786A TW201100135A (en) | 2009-06-19 | 2009-06-19 | Hypodermic syringe with retractable needle |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TW201100135A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9987428B2 (en) | 2011-10-14 | 2018-06-05 | Amgen Inc. | Injector and method of assembly |
| TWI635880B (en) * | 2013-03-22 | 2018-09-21 | 安美基公司 | Syringe and its assembly method |
| US11097055B2 (en) | 2013-10-24 | 2021-08-24 | Amgen Inc. | Injector and method of assembly |
-
2009
- 2009-06-19 TW TW98120786A patent/TW201100135A/en unknown
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11110225B2 (en) | 2011-10-14 | 2021-09-07 | Amgen Inc. | Injector and method of assembly |
| US11129941B2 (en) | 2011-10-14 | 2021-09-28 | Amgen Inc. | Method of assembling and filling a drug delivery device |
| US10314976B2 (en) | 2011-10-14 | 2019-06-11 | Amgen Inc. | Method of assembling and filling a drug delivery device |
| US10537681B2 (en) | 2011-10-14 | 2020-01-21 | Amgen Inc. | Injector and method of assembly |
| US10537682B2 (en) | 2011-10-14 | 2020-01-21 | Amgen Inc. | Injector and method of assembly |
| US12329943B2 (en) | 2011-10-14 | 2025-06-17 | Amgen Inc. | Injector and method of assembly |
| US11298463B2 (en) | 2011-10-14 | 2022-04-12 | Amgen Inc. | Method of assembling and filling a drug delivery device |
| US11058821B2 (en) | 2011-10-14 | 2021-07-13 | Amgen Inc. | Injector and method of assembly |
| US9987428B2 (en) | 2011-10-14 | 2018-06-05 | Amgen Inc. | Injector and method of assembly |
| US11273260B2 (en) | 2011-10-14 | 2022-03-15 | Amgen Inc. | Injector and method of assembly |
| US11160931B2 (en) | 2011-10-14 | 2021-11-02 | Amgen Inc. | Method of assembling and filling a drug delivery device |
| TWI635880B (en) * | 2013-03-22 | 2018-09-21 | 安美基公司 | Syringe and its assembly method |
| US11759571B2 (en) | 2013-03-22 | 2023-09-19 | Amgen Inc. | Injector and method of assembly |
| US10850037B2 (en) | 2013-03-22 | 2020-12-01 | Amgen Inc. | Injector and method of assembly |
| US11097055B2 (en) | 2013-10-24 | 2021-08-24 | Amgen Inc. | Injector and method of assembly |
| US12427260B2 (en) | 2013-10-24 | 2025-09-30 | Amgen Inc. | Injector and method of assembly |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2709546C2 (en) | Self-oriented high-pressure casing and mechanism for high pressure casing and injector connection | |
| CA2885742C (en) | Quick release plunger | |
| CN104159629B (en) | Front attachment for syringe with squeeze activated retraction | |
| RU2271835C2 (en) | Medical instrument and blocking mechanism of the instrument | |
| RU2488410C2 (en) | Syringe with deactivating mechanism | |
| ES2701166T3 (en) | Double chamber syringe with passive retraction needle | |
| CN105517606B (en) | safety syringe | |
| JP2011136151A (en) | Syringe assembly having detachable needle assembly and low dead space | |
| CN107106764A (en) | The interface of self orientation pressure jacket and pressure jacket to syringe | |
| CN104105513A (en) | Injector apparatus with fixed plunger and method of use | |
| JP2022506951A (en) | Systems and methods for injecting into multiple sites | |
| KR101334818B1 (en) | syringe | |
| EP2300082B1 (en) | Hypodermic syringe with retractable needle | |
| US20060106339A1 (en) | Medical device | |
| KR200493963Y1 (en) | Syringe with plunger reaction pressure reduction structure | |
| TW201100135A (en) | Hypodermic syringe with retractable needle | |
| CN115996773A (en) | Systems for Safety Syringes | |
| KR101479258B1 (en) | Disposable syringe | |
| CA2585297C (en) | A syringe | |
| KR101630190B1 (en) | Device for bolus administration of contrast agent | |
| RU2805000C1 (en) | Self-orienting syringe and syringe interface | |
| AU2012101441A4 (en) | Syringe Safety Prefillable | |
| CN120769759A (en) | Injection systems and methods | |
| HK1249063B (en) | Quick release plunger | |
| TWM453507U (en) | Disposable protection sleeve for dental syringe |